Nonsteroidal Antiasthma Flashcards
What is it used for
–control management of mild persistent asthma
–used to prevent symptoms from starting
–has no bronchodilating effect
Mechanism of Inflammation in Asthma: Extrinsic
–Allergic
–dust, smoke, pets
Mechanisms of inflammation in Asthma: Intrinsic
–Nonallergic
–cold air, stress, excerise
3 components of Asthma
–Acute asthma attack:resolves spontaneously or with treatment
–Hyperresponsiveness of airways to various stimuli
–Persistent inflammation that becomes worse
Cromolyn Agent: Cromolyn Sodium
–Trade Name: Disodium cromoglycate
–Mode of Action: prevents mast cell degranulation by blocking the release of chemical mediators if inflammation
–Prevents asthma triggers
–Methos od Admin: SVN 20mg/ampule or 20mg/2ml (1%)
–Side Effects: cough, nasal congestion, wheezing, nasal itching, epistaxis, nose burning
Antileukotriene Agents
–Leukotrienes are potent bronchoconstrictor and stimulate other cells to cause:
-airway edema
-mucus secretion
-ciliary beat inhibition
-recruitment of other inflammatory cells
–Alternative to steroids or cromolyn
–Used for Long-Term control
Antileukotriene Agents: Zileuton
–Trade Name: Zyflo, Zyflo CR
–Rarely Used
–Dosage and Admin: Oral, 600mg tablets,QID
Used in adults and children ages 12+
1hr before and 2 hrs after meals
–Hazards and Side effects: Headache, abdominal pain, loss of strength, dyspepsia
monitor liver function
interacts with theophylline and warfarin
Antileukotriene Agents: Zafirlukast
–Trade Name: Accolate
–Dosage and Admin: Oral admin
10mg, BID children 5/11yrs
20mg, BID 12yrs and older
–Hazards and Side Effects: headache, infection, nausea, diarrhea, generalized abdominal pain, decrease liver function
Antileukotriene Agents: Montelukast
–Trade Name: Singulair
–Dosage and Admin: Oral, 4mg or 10mg, 5mg chewable
Approved for ages 6months and up
–Hazards and side effects: diarrhea, laryngitis, pharyngitis, nausea, sinusitis, viral infection
Advantages
–oral admin
–possible once daily dosing
–safe with few side effects
–effective in aspirin sensitivity and often exercise-induced asthma
–systemic distribution reaches entire lung
–additive effect with inhaled steroids
Disadvantage
antiinflammatory action limited to one mediator pathway
–unknown long-term toxicity
–effective only to 50-70% of pt
–no predictor of pt who will respond
–systemic drug exposure
Monoclonal Antibodies: Omalizumab
–Trade Name: Xolair
–Mode of Action: blocks the attachment of IgE to mast cells reducing inflammatory mediators
–Dosage and Admin: Parenteral, 150mg/ 1.2 mL, every 2 to 4 weeks
–Hazards and side effects: anaphylaxis, injection site reactions, fever, headache, and sore throat
What kind of Asthma is associated with an allergic reaction
–extrinsic